APA

Fowler A., Koenen R., Hilbert J., Blatchford J., Kappeler D., Benediktus E., Wood C. & Gupta A. (20180530). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma. : Journal of clinical pharmacology.

Chicago

Fowler Andy, Koenen Rüdiger, Hilbert James, Blatchford Jon, Kappeler Dominik, Benediktus Ewald, Wood Chester and Gupta Abhya. 20180530. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma. : Journal of clinical pharmacology.

Harvard

Fowler A., Koenen R., Hilbert J., Blatchford J., Kappeler D., Benediktus E., Wood C. and Gupta A. (20180530). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma. : Journal of clinical pharmacology.

MLA

Fowler Andy, Koenen Rüdiger, Hilbert James, Blatchford Jon, Kappeler Dominik, Benediktus Ewald, Wood Chester and Gupta Abhya. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma. : Journal of clinical pharmacology. 20180530.